ALDH7A1 and polycystic ovary syndrome: Inverse correlations between BMI and PDE activities have been observed in subcutaneous and omental AT (43) and inhibition of PDE4 has been identified as a therapeutic target for obese women with polycystic ovary syndrome (44).